Medical-device industry urges separate legislation

The 2026 Drugs, Medical Devices and Cosmetics Bill has triggered opposition from 11 medical-device associations, which say it ignores Parliament’s calls for a separate law and regulator. The industry argues the draft retains pharma-centric terminology, criminalises technical lapses and grants excessive inspector powers, risking investment, innovation and patient safety.